Sotagliflozin manufacturer CAS:1018899-04-1

Product Description:

Product Name: Sotagliflozin CAS NO: 1018899-04-1

Synonyms:

LX4211;

LX4211/LX-4211;

Chemical & Physical Properties:

Appearance: A crystalline solid

Assay :≥98.0%

Density: 1.37±0.1 g/cm3 (Predicted)

Boiling point：607.9±55.0℃ (Predicted)

PKa: 12.87±0.70 (Predicted)

Safety Information:

Storage: -20℃

Shipping: Room Temperature in continental US; may vary elsewhere

Stability: ≥ 2 years

LX-4211 is an inhibitor of SGLT1/2 and is an anti-diabetic agent. LX-4211 is a novel oral diabetes drug developed by Sanofi and Lescon Pharmaceuticals. As a dual inhibitor of SGLT-1 and SGLT-2, the drug can reduce postprandial blood glucose, increase GLP-1 and promote urinary glucose excretion.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Please visit our website if you have any inquiry: https://www.nbinno.com. If you can't find materials from around the world, please let us know and we will research and produce them in our labs equipped with high technology.

Inno Pharmchem (Pharmaceutical Intermediates Manufacturers in China) is exclusively focusing on the manufacturing of API's Intermediates, such as Sotagliflozin, cas:1018899-04-1 , Sotagliflozin and so on. We have helped clients businesses by scaling up its pharmaceutical products through the development of innovative processes and optimizing the production process thus it making it cost-efficient.

Keywords: Sotagliflozin manufacturer;1018899-04-1 factory;Sotagliflozin producer;Sotagliflozin vendor;Sotagliflozin supplier;1018899-04-1 manufacturer.